Search results
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 1 hour agoA panel of independent advisors to the Food and Drug Administration on Monday recommended Eli...
Alzheimer's drug that can slow disease gets backing from FDA advisers
Eyewitness News Memphis· 1 hour agoA panel of Food and Drug Administration advisers voted unanimously that the drug's ability to...
FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
USA Today· 56 minutes agoA Food and Drug Administration advisory panel on Monday endorsed the experimental Alzheimer's drug...
Eli Lilly’s Alzheimer’s drug gets backing from FDA advisers
Market Watch· 30 minutes agoEli Lilly & Co.’s experimental Alzheimer’s drug donanemab on Monday moved a step closer to U.S....
FDA panel backs Lilly Alzheimer's drug
Axios· 17 minutes agoIt would compete with Eisai and Biogen's Leqembi, which the FDA approved last year. The FDA called for an outside review of donanemab earlier this year...
Mushroom-infused 'microdosing' chocolate bars are sending people to the hospital, prompting...
Fox News via Yahoo News· 2 hours agoThe FDA released an advisory about Diamond Shruumz "microdosing" chocolate bars on Friday. Consumers...
FDA and DOJ pledge more cooperation on illegal e-cigarettes ahead of congressional hearing
seattlepi.com· 6 hours agoThe Food and Drug Administration said it would launch a new task force on this issue with the...
FDA grants Shattuck Labs orphan drug status for AML treatment By Investing.com
Investing.com· 3 hours agoShattuck Labs, Inc. (NASDAQ:STTK), a biotechnology firm engaged in the development of fusion...
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 7 hours agoEli Lilly stock edged higher Monday as a panel of advisors to the Food and Drug Administration...
FDA panel votes in favor of efficacy data for Eli Lilly Alzheimer's drug
Reuters via AOL· 10 hours ago(Reuters) -Outside advisers to the U.S. Food and Drug Administration on Monday unanimously voted...
